相关实验视频
Updated: Jan 20, 2026

High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes
Published on: July 25, 2015
在基于zolbetuximab的化疗治疗后成功进行转换手术,治疗Claudin 18.2阳性胃癌,腹膜扩散和宫淋巴结转移:一个病例报告
Sadaki Shirao1, Takaaki Arigami1, Daisuke Matsushita1
1Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
以zolbetuximab为基础的化疗,随后进行手术,为晚期胃癌提供了有前途的治疗方法. 这一策略导致了显著的瘤回归和成功的转换手术在一个CLDN阳性患者.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 索尔贝图克西马布在晚期胃癌中准了克劳丁18.2 (CLDN18.2).
- 化疗后的转换手术是第四阶段胃癌的可行策略.
- 阳性CLDN18.2是索尔贝图西马布治疗的关键生物标志物.
研究的目的:
- 报告一个成功的晚期胃癌治疗案例.
- 为了评估基于佐尔贝图克西马布的化疗,然后进行转换手术的疗效.
- 要突出一种治疗策略,用于CLDN阳性胃癌与远程转移.
主要方法:
- 一名73岁的男性患有HER2阴性,CLDN阳性胃癌,接受了佐尔贝图西马布,卡佩西塔和氧沙.
- 该患者在化疗诱导的瘤回归后接受了D2淋巴切除术的亚总胃切除术 (sTG).
- 通过使用固体瘤响应评估标准 (RECIST) 和组织病理学来评估反应.
主要成果:
- 化疗导致了主要瘤,腹损伤和淋巴结转移的明显回归.
- 实现了完整的反应,宫淋巴结转移的完全解决.
- 组织病理学显示,手术后没有残留淋巴结转移的2级治疗反应.
结论:
- 以zolbetuximab为基础的化疗,然后进行转换手术是一种有前途的治疗策略.
- 这种方法可以在晚期CLDN阳性胃癌中成功进行手术切除.
- 这一案例表明了将向治疗与手术干预结合起来,改善患者治疗结果的潜力.
相关概念视频
10:02High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Lymph Node Exam
The lymphatic system has two main functions: to return extracellular fluid back to the venous circulation and to expose antigenic substances to the immune system. As the collected fluid passes through lymphatic channels on its way back to the systemic circulation, it encounters multiple nodes consisting of highly concentrated clusters of...
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
10:58Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
